The DOI matches its Crossref record; 247 of the 247 references it cites were found in a registry or an index.
Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization
Open accessAbstract
During the last few decades, improvements in the planning and application of radiotherapy in combination with surgery and chemotherapy resulted in increased survival rates of tumor patients. However, the success of radiotherapy is impaired by two reasons: firstly, the radioresistance of tumor cells and, secondly, the radiation-induced damage of normal tissue cells located in the field of ionizing radiation. These limitations demand the development of drugs for either radiosensitization of tumor cells or radioprotection of normal tissue cells. In order to identify potential targets, a detailed understanding of the cellular pathways involved in radiation response is an absolute requirement. This review describes the most important pathways of radioresponse and several key target proteins for radiosensitization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–247 of 247
The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect
Zhang, T., Shen, Y., Chen, Y., Hsieh, J., & Kong, Z. (2015) · International Journal of Radiation Biology · doi:10.3109/09553002.2015.1001531 · Cited by 63
Choy, E., Flamand, Y., Balasubramanian, S., Butrynski, J. E., Harmon, D. C., George, S., Cote, G. M., Wagner, A. J., Morgan, J. A., Sirisawad, M., et al. (2014) · Cancer · doi:10.1002/cncr.29175 · Cited by 62
Radioprotection of normal tissue cells
Maier, P. J., Wenz, F. K., & Herskind, C. (2014) · Strahlentherapie und Onkologie · doi:10.1007/s00066-014-0637-x · Cited by 62
Self-citationBoss, D. S., Schwartz, G. K., Middleton, M. R., Amakye, D. D., Swaisland, H., Midgley, R. S., Ranson, M., Danson, S. J., Calvert, H., Plummer, R., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp377 · Cited by 62
Wu, X., Wanders, A., Wardęga, P., Tinge, B., Gedda, L., Bergström, S. N., Sooman, L., Gullbo, J., Bergqvist, M., Hesselius, P., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604855 · Cited by 60
Raghavan, P., Tumati, V., Yu, L., Chan, N. H. L., Tomimatsu, N., Burma, S., Bristow, R. G., & Saha, D. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.05.035 · Cited by 60
Prasad, R., Beard, W. A., Batra, V. K., Liu, Y., Shock, D. D., & Wilson, S. H. (2011) · Molecular Biology · doi:10.1134/s0026893311040091 · Cited by 60
Endocytic Down-Regulation of ErbB2 Is Stimulated by Cleavage of Its C-Terminus
Lerdrup, M., Bruun, S., Grandal, M. V., Roepstorff, K., Kristensen, M. M., Hommelgaard, A. M., & van Deurs, B. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0025 · Cited by 60
Molecular mechanisms of individual radiosensitivity studied in normal diploid human fibroblasts
Dikomey, E., Borgmann, K., Brammer, I., & Kasten-Pisula, U. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00293-2 · Cited by 59
Cuneo, K. C., Nyati, M. K., Ray, D., & Lawrence, T. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.07.002 · Cited by 57
Histone Deacetylation as a Target for Radiosensitization
Cerna, D., Camphausen, K. A., & Tofilon, P. J. (2006) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(05)73006-4 · Cited by 57
Riesterer, O., Matsumoto, F., Wang, L., Pickett, J., Molkentine, D. P., Giri, U. P., Milas, L., & Raju, U. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9361-2 · Cited by 56
Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells
Hanashiro, K., Kanai, M., Geng, Y., Siciński, P., & Fukasawa, K. (2008) · Oncogene · doi:10.1038/onc.2008.161 · Cited by 55
Extracellular matrix and radiation G1 cell cycle arrest in human fibroblasts.
Dimitrijevic-Bussod, M., Balzaretti-Maggi, V. S., & Gadbois, D. M. (1999) · PubMed · Cited by 55
Toulany, M., Minjgee, M., Kehlbach, R., Chen, J., Baumann, M. A., & Rodemann, H. P. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.03.008 · Cited by 53
Wang, Q., Zhu, F., & Wang, Z. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.06.014 · Cited by 53
On the TRAIL from p53 to apoptosis?
Kastan, M. B. (1997) · Nature Genetics · doi:10.1038/ng1097-130 · Cited by 52
Toulany, M., Mihatsch, J., Holler, M., Chaachouay, H., & Rodemann, H. P. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.04.001 · Cited by 52
Autophagy and its function in radiosensitivity
Yang, Y., Yang, Y., Yang, X., Zhu, H., Guo, Q., Chen, X., Zhang, H., Cheng, H., & Sun, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-3496-x · Cited by 48
Yu, L., Shang, Z., Hsu, F., Zhang, Z., Tumati, V., Lin, Y., Chen, B. P. C., & Saha, D. (2015) · Oncotarget · doi:10.18632/oncotarget.2975 · Cited by 47
Androgen Receptor Signaling Fuels DNA Repair and Radioresistance in Prostate Cancer
Bártek, J., Mistrík, M., & Bártková, J. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0679 · Cited by 47
PRIMA-1met radiosensitizes prostate cancer cells independent of their MTp53-status
Supiot, S., Zhao, H. W., Wiman, K. G., Hill, R. P., & Bristow, R. G. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.01.001 · Cited by 45
Bao, Z., Cao, C., Geng, X., Tian, B., Wu, Y., Zhang, C., Chen, Z., Li, W., Shen, H., & Ying, S. (2015) · Oncotarget · doi:10.18632/oncotarget.5367 · Cited by 45
Ionizing radiation as a response‐enhancing agent for CD95‐mediated apoptosis
Sheard, M. A. (2001) · International Journal of Cancer · doi:10.1002/ijc.1020 · Cited by 44
Milanović, D., Firat, E., Grosu, A., & Niedermann, G. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-42 · Cited by 43
Mahlknecht (2009) · Oncology Reports · doi:10.3892/or_00000632 · Cited by 40
Morschhauser, F., Terriou, L., Coiffier, B., Bachy, E., Varga, A., Kloos, I., Lelièvre, H., Sarry, A.-L., Depil, S., & Ribrag, V. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0206-x · Cited by 39
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial
Shi, W., Lawrence, Y. R., Choy, H., Werner‐Wasik, M., Andrews, D. W., Evans, J. J., Judy, K. D., Farrell, C. J., Moshel, Y. A., Berger, A. C., et al. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1433-2 · Cited by 37
Kawamura, K., Morita, N., Domiki, C., Fujikawa‐Yamamoto, K., HASHIMOTO, M. W., Iwabuchi, K., & Suzuki, K. A. O. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00168.x · Cited by 36
Dogu, Y., & Díaz, J. (2009) · Biophysical Chemistry · doi:10.1016/j.bpc.2009.03.012 · Cited by 36
Membrane receptor signaling and control of DNA repair after exposure to ionizing radiation
Toulany, M., & Rodemann, H. P. (2010) · Nuklearmedizin - NuclearMedicine · doi:10.1055/s-0038-1626525 · Cited by 34
Patel, K. R., Wen, J., Magliocca, K. R., Müller, S., Liu, Y., Chen, Z. G., Saba, N. F., & Diaz, R. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2584-8 · Cited by 34
Downfall of Iniparib: A PARP Inhibitor That Doesn't Inhibit PARP After All
Sinha, G. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt447 · Cited by 33
Födermayr, M., Sebesta, M., Rudas, M., Berghoff, A. S., Promberger, R., Preusser, M., Dubsky, P. C., Fitzal, F., Gnant, M., Steger, G. G., et al. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2404-1 · Cited by 30
Epigenetic Interventions Increase the Radiation Sensitivity of Cancer Cells
Ren, J., Chu, Y., Ma, H., Zhang, Y., Zhang, X., Zhao, D., Li, Z., Wang, J., Gao, Y., Xiao, L., et al. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990529 · Cited by 30
Integrating chemoradiation and molecularly targeted therapy
Wahl, D. R., & Lawrence, T. S. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.007 · Cited by 29
Fukumoto, R., & Kiang, J. G. (2011) · Radiation Research · doi:10.1667/rr2534.1 · Cited by 26
Radiobiological aspects of intraoperative tumour-bed irradiation with low-energy X-rays (LEX-IORT)
Herskind, C., & Wenz, F. K. (2014) · Translational Cancer Research · doi:10.21037/2090 · Cited by 26
Self-citationRadiation Sensitivity of GL261 Murine Glioma Model and Enhanced Radiation Response by Flavopiridol
Newcomb, E. W., Lymberis, S. C., Lukyanov, Y., Shao, Y., Schnee, T., Devitt, M. L., Rosenstein, B. S., Zagzag, D., & Formenti, S. C. (2005) · Cell Cycle · doi:10.4161/cc.5.1.2271 · Cited by 22
Schilling, D., Düwel, M., Molls, M., & Multhoff, G. (2012) · Cell Stress and Chaperones · doi:10.1007/s12192-012-0369-8 · Cited by 19
Stachelek, G. C., Peterson-Roth, E., Liu, Y., Fernandez, R. J., Pike, L., Qian, J. M., Abriola, L., Hoyer, D., Hungerford, W. M., Merkel, J., et al. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0036 · Cited by 19
Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model
Blattmann, C., Thiemann, M., Stenzinger, A., Christmann, A., Roth, E. K., Ehemann, V., Debus, J., Kulozik, A. E., Weichert, W., Huber, P. E., et al. (2013) · Strahlentherapie und Onkologie · doi:10.1007/s00066-013-0372-8 · Cited by 18
Auf der Suche nach der Therapeutischen Breite in der Radioonkologie
Wenz, F. K., Tiefenbacher, U., Willeke, F., & Weber, K. (2001) · Oncology Research and Treatment · doi:10.1159/000055187 · Cited by 14
Self-citationApoptotic signalling in HeLa Hep2 cells following 5 Gy of cobalt-60 gamma radiation.
Eriksson, D., Löfroth, P., Johansson, L. F., Riklund, K., & Stigbrand, T. I. (2009) · PubMed · Cited by 14
Radiation-induced premature senescence is associated with specific cytogenetic changes
Zahnreich, S., Melnikova, L. S., Winter, M., Nasonova, E. A., Durante, M., Ritter, S., & Fournier, C. (2010) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2010.03.010 · Cited by 14
Herskind, C., & Westergaard, O. (1986) · Radiation Research · doi:10.2307/3576741 · Cited by 11
Self-citationĆmielová, J., Havelek, R., Vávrová, J., & Řezáčová, M. (2015) · Medical Oncology · doi:10.1007/s12032-015-0591-1 · Cited by 4
Cited by
Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
Jarosz-Biej, M., Smolarczyk, R., Cichoń, T., & Kułach, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133212 · Cited by 546
Ferroptosis, radiotherapy, and combination therapeutic strategies
Lei, G., Mao, C., Yan, Y., Zhuang, L., & Gan, B. (2021) · Protein & Cell · doi:10.1007/s13238-021-00841-y · Cited by 504
Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer
Sia, J., Szmyd, R., Hau, E., & Gee, H. E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00041 · Cited by 378
Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?
Kuo, C.-L., Ponneri Babuharisankar, A., Lin, Y.-C., Lien, H.-W., Lo, Y. K., Chou, H.-Y., Tangeda, V., Cheng, L.-C., Cheng, A. N., & Lee, A. Y.-L. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00859-2 · Cited by 351
Boron neutron capture therapy: Current status and future perspectives
Dymova, M. A., Taskaev, S. Y., Richter, V. A., & Kuligina, E. V. (2020) · Cancer Communications · doi:10.1002/cac2.12089 · Cited by 339
Metadata
- Authors
- Maier, P., Hartmann, L., Wenz, F., & Herskind, C.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2016-01-14
- Volume
- 17
- Issue
- 1
- Pages
- 102
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2238041893
- Cited by
- 414
- References
- 247
- FWCI
- 30.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.